Insider · CIK 0001886760
James F. Cummings
Files at VXRT (Vaxart, Inc.). First filing -, latest -.
In brief
James F. Cummings files SEC Form 4 as officer at VXRT (Vaxart, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James F. Cummings has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 28, 2026 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -3,292 | $0.65 | $2,140 | 924,177 | Mar 31, 2026 |
| Mar 24, 2026 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -30,551 | $0.69 | $21k | 927,469 | Mar 26, 2026 |
| Mar 18, 2026 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -6,772 | $0.63 | $4,298 | 958,020 | Mar 20, 2026 |
| Mar 16, 2026 | VXRT Vaxart, Inc. | AGrant or award Common Stock | +227,000 | $0.00 | $0 | 964,792 | Mar 18, 2026 |
| Mar 16, 2026 | VXRT Vaxart, Inc. | AGrant or award Stock Option (right to buy)derivative | +455,000 | $0.00 | $0 | 455,000 | Mar 18, 2026 |
| Feb 2, 2026 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -7,965 | $0.61 | $4,847 | 737,792 | Feb 5, 2026 |
| Mar 28, 2025 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -3,292 | $0.42 | $1,387 | 745,757 | Apr 1, 2025 |
| Mar 24, 2025 | VXRT Vaxart, Inc. | AGrant or award Common Stock | +406,000 | $0.00 | $0 | 749,049 | Mar 26, 2025 |
| Mar 24, 2025 | VXRT Vaxart, Inc. | AGrant or award Stock Option (right to buy)derivative | +610,000 | $0.00 | $0 | 610,000 | Mar 26, 2025 |
| Mar 24, 2025 | VXRT Vaxart, Inc. | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Mar 26, 2025 |
| Mar 28, 2023 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -3,267 | $0.75 | $2,451 | 349,821 | Mar 20, 2025 |
| Mar 18, 2025 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -6,772 | $0.57 | $3,861 | 343,049 | Mar 20, 2025 |
| Feb 2, 2025 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -7,964 | $0.68 | $5,414 | 318,837 | Feb 4, 2025 |
Questions about James F. Cummings
Answered from the filings on this page, as of the latest one.
Is James F. Cummings buying or selling?
James F. Cummings has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James F. Cummings's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James F. Cummings has 0.
Where does James F. Cummings file Form 4?
James F. Cummings has filed Form 4 at VXRT (Vaxart, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.